BioCentury
ARTICLE | Company News

Innovir other research news

March 30, 1998 8:00 AM UTC

INVR, a subsidiary of VimRx Pharmaceuticals Inc. (VMRX, Wilmington, Del.), reported development of the FRS technology, which identifies sites in messenger RNA molecules that can be cleaved by a riboz...